Eywa Pharma is a U.S. based pharmaceuticals company with a diverse product portfolio including oral solids and liquids, for niche, limited competition and high volume products. Eywa Pharma is led by a seasoned team with deep industry experience who are passionately committed to Eywa’s goal of making available affordable high quality medicines to patients – the “Eywa Way”. Eywa’s business model is well positioned to capitalize on the changing trends in the U.S. generics market. Understanding market needs, portfolio selection, strategic partnerships and execution capability are the pillars on which Eywa Pharma has built its business. In 2020, Eywa established its U.S. manufacturing facility in Cranbury, NJ, to access both the U.S. Government market and mitigate the global supply chain challenges.

Milestones

Manufacturing

Eywa has established a state-of-the-art oral solid dosage manufacturing facility in Cranbury, New Jersey, USA. This facility manufactures tablets, capsules and oral suspensions.

Our team possess extensive experience in commercial manufacturing of high quality generic pharmaceuticals in a cGMP compliant environment, including successful technology transfers.

Development

Eywa has established a state-of-the-art facility for development of generic pharmaceuticals with pilot scale manufacturing capabilities.

Our team of highly experienced scientists use robust technologies to develop high quality generic pharmaceuticals, covering a variety of therapeutic areas and dosage forms.

Quality

At Eywa, Quality is a way of life. Our highest priority is Quality by Design (QbD) in everything that we do. With the objective of continuous improvement, we challenge and constantly train ourselves as a team. Our systems, protocols and procedures have been designed to promote constant training, monitoring and review.

We believe in setting and exceeding high quality standards and expect the same of our partners and suppliers. Therefore, we continuously ensure that quality systems across our partners’ and our development and manufacturing facilities, meet and exceed the standards set forth by the regulatory bodies around the world.